Follow on Google News
News By Tag
News By Place
Follow on Google News
Absorbable Nasal Implant Devices Market Analysis-2027
Absorbable Nasal Implant Devices Market Report- Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
Nasal valve collapse impacts the patient's quality of life significantly. This condition is severe in some patients, and has limited number of treatment options. Moreover, most of the treatment options are invasive and the only permanent solution is to undergo a nasal valve surgery. This requires extensive skills and training by the ENT specialist or facial plastic surgeons.
Alternate Treatment Options for Nasal Valve Collapse
One of the convenient options is the nasal valve dilator – Breathe Right strips being sold in the market. Nasal valve dilators are available in two options – one that can be worn internally and other that is stuck externally (Breathe Right strips). Other option is rhinoplasty with or without graft to repair the nasal valve collapse.
Latera is designed using a copllymer, which gets absorbed in the body over a period of approximately 18 months. The product includes a delivery device and an implant positioning guide in the accessories. The single use delivery device is composed of a handle body, a deployment plunger and pushrod, and a 16-gauge delivery cannula with a depth marker and protective cover.
Browse Research Report: https://www.coherentmarketinsights.com/
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/
Increasing clinical tests of trademarked products by key players is expected to drive growth of the market during the forecast period. In June 2019, Stryker Corporation announced that 33,000 patients were treated with company's LATERA absorbable nasal implant device. The device is used to support the lateral nasal cartilage and address the symptoms of NVC, which help the patients to breathe better.
Key players are involved in various business strategies such as product launch to gain the competitive edge in the market. In April 2018, Intersect ENT announced the launch of its SINUVA sinus implant, which is a novel in-office treatment option for recurrent nasal polyps. It is a clinically proven treatment for patients suffering from nose, throat, and ear conditions.
Buy-Now this research report: https://www.coherentmarketinsights.com/